Germany· DE-A57-d5c97661553cb3fc
Trasylol
A aprotinin product containing aprotinin, registered in Germany by Nordic Group B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Aprotinin is registered in 11 of 19 countries.
Countries holding a registration under ATC B02AB01 (aprotinin), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 6 of them publish a price we can compare per daily dose
Aprotinin · ATC B02AB01
11 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Aprotinin
- Manufacturer
- Nordic Group B.V.
- Country
- Germany (DE)
- ATC code
- B02AB01
- ATC class
- Aprotinin
- Defined daily dose
- 500 TSD, E
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
6 interactions on record for aprotinin.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Aprotinin · interactions on record
6 records
- 3 severe
- 3 moderate
Most severe, free to view
- Faktor VIII-Inhibitor Bypass Aktivität - FEIBAB02BD03severe
- TretinoinL01XF01severe
- TretinoinL01XX14severe
- AlteplaseB01AD02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Aprotinin in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAprotinin 15,000 Kallikrein inactivator units/5ml irrigation solution vialsBaxter Healthcare Ltd
- BelgiumTisseel S/DBaxter
- FinlandTrasylolNordic Group B.V.
- FranceTRASYLOL 500 000 UIK/50 mL, solution injectableNORDIC GROUP (PAYS-BAS)
- IrelandTrasylol 10,000 KIU/ml, solution for injection or infusionNordic Group B.V.
- NetherlandsTrasylol, oplossing voor infusie 10.000 KIE/mlNordic Group B.V.
- NorwayTrasylolNordic Group
- PolandTrasylolNordic Group B.V.
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Trasylol
- Belgium · Trasylol
- Denmark · Trasylol
- Finland · Trasylol
- France · Trasylol
- United Kingdom (Northern Ireland) · Aprotinin
- Hungary · Gordox
- Ireland · Trasylol
- Luxembourg · Trasylol
- Netherlands · Trasylol
- Poland · Trasylol
- Portugal · Trasylol
- Sweden · Trasylol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/562f8b20-7494-4c13-b297-c797e7d2db5b GET /v1/drugs/562f8b20-7494-4c13-b297-c797e7d2db5b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Aprotinin",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about aprotinin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.